
Sign up to save your podcasts
Or
Dr. Mandelbrodt discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.
4.7
2424 ratings
Dr. Mandelbrodt discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.
60 Listeners
7,700 Listeners
493 Listeners
43,465 Listeners
3,332 Listeners
420 Listeners
549 Listeners
14,393 Listeners
8,210 Listeners
203 Listeners
57,990 Listeners
28,304 Listeners
41,337 Listeners
20,479 Listeners
7,304 Listeners